Actinium Pharmaceuticals Stock Momentum Indicators Williams R percentage
| ATNM Stock | USD 1.44 0.03 2.13% |
| Symbol |
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Williams %R value was developed by Larry Williams and ranges from zero to 100. The values are charted on an inverted scale. Values below 20 indicate an overbought condition for Actinium Pharmaceuticals and a sell signal is generated when it crosses the 20 line. Values over 80 indicate an oversold condition for Actinium Pharmaceuticals and a buy signal is generated when it crosses the 80 line.
Actinium Pharmaceuticals Technical Analysis Modules
Most technical analysis of Actinium Pharmaceuticals help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Actinium from various momentum indicators to cycle indicators. When you analyze Actinium charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Actinium Pharmaceuticals Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Actinium Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Actinium Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Actinium Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Actinium Pharmaceuticals's daily price indicators and compare them against related drivers, such as momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Actinium Pharmaceuticals's intrinsic value. In addition to deriving basic predictive indicators for Actinium Pharmaceuticals, we also check how macroeconomic factors affect Actinium Pharmaceuticals price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2010 | 2023 (projected) | Dividend Yield | 3.9E-5 | 1.2E-5 | Price To Sales Ratio | 108.06 | 1.7K |
Be your own money manager
As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.Generate Optimal Portfolios
Align your risk and return expectations
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Actinium Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Actinium Stock, please use our How to Invest in Actinium Pharmaceuticals guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Actinium Pharmaceuticals. If investors know Actinium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Actinium Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.39) | Revenue Per Share 0.003 | Quarterly Revenue Growth (1.00) | Return On Assets (0.31) | Return On Equity (0.88) |
The market value of Actinium Pharmaceuticals is measured differently than its book value, which is the value of Actinium that is recorded on the company's balance sheet. Investors also form their own opinion of Actinium Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Actinium Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Actinium Pharmaceuticals' market value can be influenced by many factors that don't directly affect Actinium Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Actinium Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Actinium Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Actinium Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.